SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Teva to pay $450 million over Copaxone price inflation

Asus Zenbook S 14 embraces AI revolution with Intel's Core Ultra Processor

Hezbollah missiles threaten Adani's Haifa Port: What happens if Israel’s key trade hub shuts down?

TechnoPulm raises $2 million to develop a handheld device capable of performing full lung function tests

Buzz

Most popular

Daily

Weekly

1

Intel employees brace for layoff notices as cuts to move into high gear next week

2

"We’ll be looking out for you": Intel CEO Gelsinger stands with Israeli team

3

Bill Ackman sees 80% return on Tel Aviv Stock Exchange investment in just 10 months

4

Prime Security nets $6 million in Seed to build guardrails into the software design phase

5

Snyk cuts losses by a third, boosts revenue by 50%, as it prepares for IPO

Quris

7 stories about Quris

Michel Yossi Quris

Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles

Vounatsos was appointed Board member and Ben Amram was appointed President, respectively.

ד״ר צחון בנטואיץ׳ מייסד משותף של קיוריס Quris AI

Pharma giant Merck expands collaboration with Quris-AI

28.09.23|Meir Orbach

This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches

יוסי הרן צחון בנטואיץ Quris

SoftBank leads $9 million investment in AI pharma startup Quris

20.12.22|Meir Orbach

The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials

Isaac Bentwich BiblioTech

CTech’s Book Review: Breaking down the barriers to set you free

13.07.22|Isaac Bentwich

Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer

מימין אהרון צ'חנובר יו"ר הוועדה המדעית בקיוריס והמנכ"ל צחון בנטואיץ'

Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction

09.02.22|Meir Orbach

The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant

Quris Isaac Bentwich

Quris closes record $28 million Seed funding for AI drug development platform

11.01.22|Meir Orbach

The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing

Quris Isaac Bentwich

Quris raises $9 million in Seed for its clinician prediction AI platform

21.10.21|James Spiro

The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.